4.5 Editorial Material

UAE efforts in promoting COVID-19 vaccination and building vaccine confidence Comment

Journal

VACCINE
Volume 39, Issue 43, Pages 6341-6345

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2021.09.015

Keywords

UAE; Vaccination program; COVID-19 Vaccine; Vaccine Hesitancy; COVID-19 response

Funding

  1. Mohammed Bin Rashid School of Government, Dubai, UAE
  2. Alliance for Health Policy and Systems Research at the World Health Organization as part of the Knowledge to Policy (K2P) Center Mentor-ship Program [BIRD Project]

Ask authors/readers for more resources

The UAE has taken the lead globally in addressing the COVID-19 pandemic, with significant achievements in preventive measures, free vaccine distribution, and public health strategies. Over 70% of the population has been fully vaccinated, marking a successful vaccination program in the country. The efforts to provide third doses to high-risk individuals and achieving herd immunity showcase the UAE's commitment to combating the pandemic.
The United Arab Emirates (UAE) is leading globally in many indicators for tackling the COVID-19 pandemic. This ranges from taking adequate preventive measures to the free vaccination drive and viable public health strategy. As of 18 August 2021, the UAE has significantly reduced the number of cases and successfully administered 17,454,250 doses. Furthermore, efforts and plans are underway to provide the third dose to high-risk people three months after completing the second dose and six months later to others. The UAE is considered one of the leaders globally for vaccinating medically eligible residents against COVID-19, with over 70% of the population currently fully vaccinated in the drive towards achieving herd immunity. The UAE's vaccination program is on track, covering a significant part of the population. The massive efforts of the National Vaccination Program's roll-out made by the UAE government and the various health authorities and stakeholders were vital for the general public's active participation in its success. (C) 2021 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available